Characterization of a severe hypofibrinogenemia induced by alteplase in two patients thrombolysed for stroke

Thrombosis Research

Volumn 131, Issue 1, 2013, Pages

  Matrat, Aurélie ^a   De Mazancourt, Philippe ^b,c   Derex, Laurent ^a   Nighoghossian, Norbert ^a   Ffrench, Patrick ^a   Rousson, Robert ^a   Hanss, Michel ^a  

^a HOSPICES CIVILS DE LYON   (France)

^b CENTRE HOSPITALIER INTERCOMMUNAL   (France)

^c LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ALTEPLASE; FIBRINOGEN;

AGED; APHASIA; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; DRUG INDUCED DISEASE; FEMALE; FIBRINOGEN BLOOD LEVEL; FIBRINOGEN METABOLISM; FIBRINOGENOLYSIS; HEMIPLEGIA; HUMAN; HYPOFIBRINOGENEMIA; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

AFIBRINOGENEMIA; AGED; ALPHA-2-ANTIPLASMIN; BIOLOGICAL MARKERS; DOWN-REGULATION; FEMALE; FIBRIN FIBRINOGEN DEGRADATION PRODUCTS; FIBRINOLYTIC AGENTS; HUMANS; INTRACRANIAL HEMORRHAGES; MALE; PLASMINOGEN; SEVERITY OF ILLNESS INDEX; STROKE; THROMBOLYTIC THERAPY; TIME FACTORS; TISSUE PLASMINOGEN ACTIVATOR;

EID: 84871661821     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2012.11.009     Document Type: Letter

References (20)

1. H.P. Adams Jr., G. del Zoppo, M.J. Alberts, D.L. Bhatt, L. Brass, and A. Furlan Guidelines for the early management of adults with ischemic stroke Stroke 38 2007 1655 1711
2. L. Derex, and N. Nighoghossian Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update J Neurol Neurosurg Psychiatry 79 2008 1093 1099
3. P. Trouillas, L. Derex, F. Philippeau, N. Nighoghossian, J. Honnorat, and M. Hanss Early fibrinogen degradation coagulopathy is predictive of parenchyma hematomas in cerebral rt-PA thrombolysis. A study of 157 cases Stroke 35 2004 1323 1328 (Pubitemid 38697451)
4. D. Collen The plasminogen (fibrinolytic) system Thromb Haemost 82 1999 259 270
5. A. Alonso, C.E. Dempfle, K. Szabo, K. Zohsel, and M.G. Hennerici Drop of PT Quick percent value is associated with both symptomatic and asymptomatic intracranial hemorrhage in patients treated with rt-PA for acute ischemic stroke Thromb Res 127 2011 65 66
6. D. Cocho, M. Borrell, J. Martí-Fàbregas, J. Montaner, M. Castellanos, and Y. Bravo Pretreatment hemostatic markers of symptomatic intracerebral hemorrhage in patients treated with tissue plasminogen activator Stroke 37 2006 996 999
7. M. Hanss, C. Pouymayou, M.T. Blouch, F. Lellouche, P. Ffrench, and R. Rousson The natural occurrence of human fibrinogen variants disrupting inter-chain disulfide bonds (AαCys36Gly, AαCys36Arg and AαCys45Tyr) confirms the role of N-terminal Aα disulfide bonds in protein assembly and secretion Haematologica 96 2011 1226 1230
8. P.J. Gaffney Breakdown products of fibrin and fibrinogen: molecular mechanisms and clinical implications J Clin Pathol 33 1980 10 17
9. C.M. Lawler, E.G. Bovill, D.C. Stump, D.J. Collen, K.G. Mann, and R.P. Tracy Fibrin fragment D-dimer and fibrinogen B beta peptides in plasma as markers of clot lysis during thrombolytic therapy in acute myocardial infarction Blood 76 1990 1341 1348 (Pubitemid 20342749)
10. G.D. Lowe, A. Rumley, and I.J. Mackie Plasma fibrinogen Ann Clin Biochem 41 2004 430 440 (Pubitemid 39573999)
11. R. Park, H.J. Doh, S.S. An, J.R. Choi, K.H. Chung, and K.S. Song A novel fibrinogen variant (fibrinogen Seoul II; AalphaGln328Pro) characterized by impaired fibrin alpha-chain cross-linking Blood 108 2006 1919 1924 (Pubitemid 44395001)
12. V. Ivaskevicius, E. Jusciute, M. Steffens, C. Geisen, P. Hanfland, and T.F. Wienker Gamma Ala82Gly represents a common fibrinogen gamma-chain variant in Caucasians Blood Coagul Fibrinolysis 16 2005 205 208 (Pubitemid 40547276)
13. J. Wyatt, S.O. Brennan, S. May, and P.M. George Hypofibrinogenaemia with compound heterozygosity for two gamma chain mutations - gamma 82 Ala > Gly and an intron two GT > AT splice site mutation Thromb Haemost 84 2000 449 452
14. M. Hanss, and F. Biot A database of fibrinogen variant Ann N Y Acad Sci 936 2001 89 90
15. M.W. Mosesson, K.R. Siebenlist, I. Hernandez, K.N. Lee, V.J. Christiansen, and P.A. McKee Evidence that alpha2-antiplasmin becomes covalently ligated to plasma fibrinogen in the circulation: a new role for plasma factor XIII in fibrinolysis regulation J Thromb Haemost 6 2008 1565 1570
16. G. Tsurupa, and L. Medved Identification and characterization of novel tPA- and plasminogen-binding sites within fibrin(ogen) αC-domains Biochemistry 40 2001 801 808 (Pubitemid 32096865)
17. M.J. Heeb, F. España, M. Geiger, D. Collen, D.C. Stump, and J.H. Griffin Immunological identity of heparin-dependent plasma and urinary protein C inhibitor and plasminogen activator inhibitor-3 J Biol Chem 262 1987 15813 15816 (Pubitemid 17165185)
18. S.M. Jafri, E.F. Mammen, J. Masura, and S. Goldstein Effects of warfarin on markers of hypercoagulability in patients with heart failure Am Heart J 134 1997 27 36 (Pubitemid 27329020)
19. J.I. Weitz, B. Leslie, and J. Ginsberg Soluble fibrin degradation products potentiate tissue plasminogen activator-induced fibrinogen proteolysis J Clin Invest 87 1991 1082 1090
20. A.H. Hendschen-Edman Fibrinogen non-inherited heterogeneity and its relationship to function in health and disease Ann N Y Acad Sci 936 2001 580 593